scholarly journals An Algorithm That Identifies Coronary and Heart Failure Events in the Electronic Health Record

2013 ◽  
Vol 10 ◽  
Author(s):  
Thomas E. Kottke ◽  
Courtney Jordan Baechler
2020 ◽  
Vol 13 (Suppl_1) ◽  
Author(s):  
Evan Claggett ◽  
Rachel H Krallman ◽  
Delaney Feldeisen ◽  
Daniel G Montgomery ◽  
Kim Eagle ◽  
...  

Background: The effects of sleep deprivation are vast, ranging from increased stress responses, to lowered immunity and delayed wound healing. However, sleep disruptions are common in the inpatient setting. This study sought to quantify the number and frequency of inpatient sleep disturbances and analyze post-discharge outcomes (emergency department visit, readmission, death) among congestive heart failure (CHF) patients. Methods: Data were collected retrospectively from 30 randomly selected patients admitted for CHF and referred to a cardiac transitional care clinic from 2014 to 2017. Each night over the course of the hospitalization was broken into 12 one-hour intervals (1900-0659 hours), and the electronic health record was examined for 20 variables indicative of sleep disruption (e.g. vitals taken, medications dispensed, wound care) (Figure 1). Demographics and outcomes were compared between high (above median) and low (below median) groups for average number of nightly interval interruptions and average longest uninterrupted sleep interval (LUSI). Results: On average, patients had a length of admission of 5.4 nights, a LUSI of 2.9 hours (range: 1-4), and 6.3 disruptions between 1900-0659 hours (range: 3-8). The readmission rates for the total population were 23% at 30 days and 63% at 180 days. No significant differences were seen in demographics or outcomes up to 180 days post-discharge when comparing high and low patient groups in either average nightly interval interruptions or average LUSI. Conclusion: Although no differences were seen between groups, the majority of patients had poor outcomes (23% were readmitted at 30 days; 63% at 180 days) as well as poor sleep during their admission. The lack of sleep across the entire patient population may be contributing to the poor outcomes observed. Many of the variables reviewed (e.g. vitals taken, medications dispensed, etc.) had potentially elective timing, which suggests actionable changes to the inpatient process may be possible to improve sleep quantity and quality. This was an exploratory pilot study to determine the ability to use electronic health record data for this purpose. As such, the sample size was too small to detect differences. A larger sample size is needed to better understand the extent to which sleep disruptions impact patient outcomes.


2015 ◽  
Vol 22 (2) ◽  
pp. 299-311 ◽  
Author(s):  
Nicholas D Soulakis ◽  
Matthew B Carson ◽  
Young Ji Lee ◽  
Daniel H Schneider ◽  
Connor T Skeehan ◽  
...  

Abstract Objective To visualize and describe collaborative electronic health record (EHR) usage for hospitalized patients with heart failure. Materials and methods We identified records of patients with heart failure and all associated healthcare provider record usage through queries of the Northwestern Medicine Enterprise Data Warehouse. We constructed a network by equating access and updates of a patient’s EHR to a provider-patient interaction. We then considered shared patient record access as the basis for a second network that we termed the provider collaboration network. We calculated network statistics, the modularity of provider interactions, and provider cliques. Results We identified 548 patient records accessed by 5113 healthcare providers in 2012. The provider collaboration network had 1504 nodes and 83 998 edges. We identified 7 major provider collaboration modules. Average clique size was 87.9 providers. We used a graph database to demonstrate an ad hoc query of our provider-patient network. Discussion Our analysis suggests a large number of healthcare providers across a wide variety of professions access records of patients with heart failure during their hospital stay. This shared record access tends to take place not only in a pairwise manner but also among large groups of providers. Conclusion EHRs encode valuable interactions, implicitly or explicitly, between patients and providers. Network analysis provided strong evidence of multidisciplinary record access of patients with heart failure across teams of 100+ providers. Further investigation may lead to clearer understanding of how record access information can be used to strategically guide care coordination for patients hospitalized for heart failure.


2012 ◽  
Vol 35 (3) ◽  
pp. 187-196 ◽  
Author(s):  
Mary Norine Walsh ◽  
Nancy M. Albert ◽  
Anne B. Curtis ◽  
Mihai Gheorghiade ◽  
J. Thomas Heywood ◽  
...  

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
E Loefroth ◽  
M Hughes ◽  
Y Shi ◽  
Y Wang ◽  
C Proudfoot ◽  
...  

Abstract Background and purpose Sacubitril/valsartan (sac/val), an angiotensin receptor neprilysin inhibitor, reduces the risk for cardiovascular (CV) death or hospitalization for heart failure (HF) in HF with reduced ejection fraction (HFrEF). Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are approved in patients with type 2 diabetes (T2D) and have shown to reduce the CV risk in T2D patients with established CV or at risk of CV disease. The SGLT2i dapagliflozin has shown to improve outcomes in patients with chronic HFrEF, with or without T2D, when used in addition to standard of care including sac/val. As the use of SGLT2i in HF evolves, and given the large overlap of HF and T2D populations, it is of interest to understand the population with concomitant use of sac/val and SGLT2i. This study describes the clinical characteristics of patients treated concomitantly with sac/val and SGLT2i or concomitantly with sac/val and dipeptidyl peptidase-4 inhibitors (DPP4i) or glucagon-like peptide-1 receptor agonists (GLP1), two comparable second line anti-diabetic drug classes. Methods This retrospective non-interventional study describes two mutually exclusive adult patient cohorts diagnosed with HF and T2D concomitantly prescribed sac/val and SGLT2i (cohort 1), or concomitantly prescribed sac/val and DDP4i/GLP1 (cohort 2). The index date was defined as the first date of concomitant use with prescriptions overlapping a minimum of 21 days. Patients were identified any time between 1/1/2015 and 30/6/2019 in the Optum® de-identified electronic health record (EHR) data from providers across the continuum of care. Results 2.3 million HF patients were identified, and 41.6% had a T2D diagnosis. 560 patients were concomitantly prescribed sac/val and SGLT2i (cohort 1) and 1,566 concomitantly sac/val and DDP4/GLP1 (cohort 2). There was a higher proportion of females in cohort 2 (35.0% vs 27.9%). Mean age was higher in cohort 2 (66.4 vs 61.4 years). The mean estimated glomerular filtration rate was 85.93 (SD 23.43) ml/min/1.73m2 (cohort 1) and 72.10 (Std. 27.11) ml/min/1.73m2 (cohort 2). The proportion of stage 3 CKD (<60 to >30 ml/min/1.73m2) was 11.8% (cohort 1) and 24.4% (cohort 2). Mean systolic blood pressure was similar, 120 mmHg (cohort 1) and 122 mmHg (cohort 2). Mean hemoglobin was 13.60 g/dl (cohort 1) and 12.43 g/dl (cohort 2). Median (IQR) NT-proBNP differed between the two cohorts, 914 (2154) pg/ml (cohort 1) and 2,290 (5,301) pg/ml (cohort 2) but with complete values available in only 17.7 and 19.0% of each cohort. Conclusions This descriptive analysis of concomitant prescription of sac/val and SGLT2i or DPP4/GLP1 highlights differences in the clinical characteristics between the two cohorts. The patients treated with sac/val and SGLT2i start with a more favorable clinical profile compared to the patients treated with sac/val and DPP4/GLP1. Further analyses are needed to determine if these differences are driven by age, gender or other factors. Funding Acknowledgement Type of funding source: Private company. Main funding source(s): Novartis Pharma AG


2014 ◽  
Vol 05 (03) ◽  
pp. 670-684 ◽  
Author(s):  
P. Marken ◽  
Y. Zhong ◽  
S. D. Simon ◽  
W. Ketcherside ◽  
M. E. Patterson

SummaryBackground: Regulatory standards for 30-day readmissions incentivize hospitals to improve quality of care. Implementing comprehensive electronic health record systems potentially decreases readmission rates by improving medication reconciliation at discharge, demonstrating the additional benefits of inpatient EHRs beyond improved safety and decreased errors.Objective: To compare 30-day all-cause readmission incidence rates within Medicare fee-for-service with heart failure discharged from hospitals with full implementation levels of comprehensive EHR systems versus those without.Methods: This retrospective cohort study uses data from the American Hospital Association Health IT survey and Medicare Part A claims to measure associations between hospital EHR implementation levels and beneficiary readmissions. Multivariable Cox regressions estimate the hazard ratio of 30-day all-cause readmissions within beneficiaries discharged from hospitals implementing comprehensive EHRs versus those without, controlling for beneficiary health status and hospital organizational factors. Propensity scores are used to account for selection bias.Results: The proportion of heart failure patients with 30-day all-cause readmissions was 30%, 29%, and 32% for those discharged from hospitals with full, some, and no comprehensive EHR systems. Heart failure patients discharged from hospitals with fully implemented comprehensive EHRs compared to those with no comprehensive EHR systems had equivalent 30-day readmission incidence rates (HR = 0.97, 95% CI 0.73 – 1.3)Conclusions: Implementation of comprehensive electronic health record systems does not necessarily improve a hospital’s ability to decrease 30-day readmission rates. Improving the efficiency of post-acute care will require more coordination of information systems between inpatient and ambulatory providers.Citation: Patterson ME, Marken P, Zhong Y, Simon SD, Ketcherside W. Comprehensive electronic medical record implementation levels not associated with 30-day all-cause readmissions within Medicare beneficiaries with heart failure. Appl Clin Inf 2014; 5: 670–684http://dx.doi.org/10.4338/ACI-2014-01-RA-0008


2020 ◽  
Vol 26 (12) ◽  
pp. 1060-1066
Author(s):  
Parag Goyal ◽  
Budhaditya Bose ◽  
Ruth Masterson Creber ◽  
Udhay Krishnan ◽  
Mei Yang ◽  
...  

2020 ◽  
Vol 2 ◽  
Author(s):  
Aixia Guo ◽  
Randi E. Foraker ◽  
Robert M. MacGregor ◽  
Faraz M. Masood ◽  
Brian P. Cupps ◽  
...  

Objective: Although many clinical metrics are associated with proximity to decompensation in heart failure (HF), none are individually accurate enough to risk-stratify HF patients on a patient-by-patient basis. The dire consequences of this inaccuracy in risk stratification have profoundly lowered the clinical threshold for application of high-risk surgical intervention, such as ventricular assist device placement. Machine learning can detect non-intuitive classifier patterns that allow for innovative combination of patient feature predictive capability. A machine learning-based clinical tool to identify proximity to catastrophic HF deterioration on a patient-specific basis would enable more efficient direction of high-risk surgical intervention to those patients who have the most to gain from it, while sparing others. Synthetic electronic health record (EHR) data are statistically indistinguishable from the original protected health information, and can be analyzed as if they were original data but without any privacy concerns. We demonstrate that synthetic EHR data can be easily accessed and analyzed and are amenable to machine learning analyses.Methods: We developed synthetic data from EHR data of 26,575 HF patients admitted to a single institution during the decade ending on 12/31/2018. Twenty-seven clinically-relevant features were synthesized and utilized in supervised deep learning and machine learning algorithms (i.e., deep neural networks [DNN], random forest [RF], and logistic regression [LR]) to explore their ability to predict 1-year mortality by five-fold cross validation methods. We conducted analyses leveraging features from prior to/at and after/at the time of HF diagnosis.Results: The area under the receiver operating curve (AUC) was used to evaluate the performance of the three models: the mean AUC was 0.80 for DNN, 0.72 for RF, and 0.74 for LR. Age, creatinine, body mass index, and blood pressure levels were especially important features in predicting death within 1-year among HF patients.Conclusions: Machine learning models have considerable potential to improve accuracy in mortality prediction, such that high-risk surgical intervention can be applied only in those patients who stand to benefit from it. Access to EHR-based synthetic data derivatives eliminates risk of exposure of EHR data, speeds time-to-insight, and facilitates data sharing. As more clinical, imaging, and contractile features with proven predictive capability are added to these models, the development of a clinical tool to assist in timing of intervention in surgical candidates may be possible.


Sign in / Sign up

Export Citation Format

Share Document